1. Home
  2. ECPG vs SBFM Comparison

ECPG vs SBFM Comparison

Compare ECPG & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encore Capital Group Inc

ECPG

Encore Capital Group Inc

HOLD

Current Price

$67.56

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.06

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECPG
SBFM
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
6.0M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
ECPG
SBFM
Price
$67.56
$1.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$77.33
$7.00
AVG Volume (30 Days)
270.7K
31.9K
Earning Date
05-06-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
287.14
N/A
EPS
10.91
N/A
Revenue
$1,768,802,000.00
N/A
Revenue This Year
$3.63
$10.26
Revenue Next Year
$4.47
$32.63
P/E Ratio
$6.35
N/A
Revenue Growth
34.37
N/A
52 Week Low
$26.45
$1.05
52 Week High
$74.58
$3.90

Technical Indicators

Market Signals
Indicator
ECPG
SBFM
Relative Strength Index (RSI) 57.36 32.56
Support Level $65.01 N/A
Resistance Level $74.58 $1.52
Average True Range (ATR) 2.67 0.05
MACD -0.39 -0.00
Stochastic Oscillator 26.44 0.00

Price Performance

Historical Comparison
ECPG
SBFM

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Share on Social Networks: